What is CollPlant Biotechnologies Inventory-to-Revenue?
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. CollPlant Biotechnologies's Average Total Inventories for the quarter that ended in Mar. 2024 was $0.68 Mil. CollPlant Biotechnologies's Revenue for the
three
months ended in Mar. 2024 was $0.10 Mil.
CollPlant Biotechnologies's Inventory-to-Revenue for the quarter that ended in Mar. 2024 was 6.93.
CollPlant Biotechnologies's Inventory-to-Revenue for the quarter that ended in Mar. 2024
increased
from Dec. 2023 (3.71) to Dec. 2023 (6.93)
An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:
1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
CollPlant Biotechnologies's Days Inventory for the
three
months ended in Mar. 2024 was 113.77.
Inventory Turnover measures how fast the company turns over its inventory within a year.
CollPlant Biotechnologies's Inventory Turnover for the quarter that ended in Mar. 2024 was 0.80.
CollPlant Biotechnologies Inventory-to-Revenue Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of CollPlant Biotechnologies's Inventory-to-Revenue
For the Biotechnology subindustry, CollPlant Biotechnologies's Inventory-to-Revenue, along with its competitors' market caps and Inventory-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CollPlant Biotechnologies's Inventory-to-Revenue Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, CollPlant Biotechnologies's Inventory-to-Revenue distribution charts can be found below:
* The bar in red indicates where CollPlant Biotechnologies's Inventory-to-Revenue falls into.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
CollPlant Biotechnologies's Inventory-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
An increase in Inventory-to-Revenue from one quarter to the next indicates that one of the following is happening:
1. investment in inventory is growing more rapidly than revenue
2. revenue are dropping
No matter which situation is causing the problem, an increase in the Inventory-to-Revenue may signal an oncoming cash flow problem.
Likewise, a decrease in the Inventory-to-Revenue from one quarter to next indicates that one of these is occurring:
1. investment in inventory is shrinking in relation to revenue
2. revenue are increasing
No matter which situation is causing the reduction in the Inventory-to-Revenue, either one suggests that business's inventory levels and its cash flow are effectively managed.
More Related Terms:
1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
CollPlant Biotechnologies's Days Inventory for the
three
months ended in Mar. 2024 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CollPlant Biotechnologies Inventory-to-Revenue Related Terms
Thank you for viewing the detailed overview of CollPlant Biotechnologies's Inventory-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
CollPlant Biotechnologies (CollPlant Biotechnologies) Business Description
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The company's revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CLGN has been successfully added to your 